PELP1/SRC-3-dependent regulation of metabolic PFKFB kinases drives therapy resistant ER+ breast cancer.
Truong TH, Benner EA, Hagen KM, Temiz NA, Kerkvliet CP, Wang Y, Cortes-Sanchez E, Yang CH, Trousdell MC, Pengo T, Guillen KP, Welm BE, Dos Santos CO, Telang S, Lange CA, Ostrander JH.
Truong TH, et al. Among authors: hagen km.
Oncogene. 2021 Jun;40(25):4384-4397. doi: 10.1038/s41388-021-01871-w. Epub 2021 Jun 8.
Oncogene. 2021.
PMID: 34103681
Free PMC article.